AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Abnib 250mg Tablet

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Lapatinib (250mg)

Overview Abnib 250mg Tablet

Oncaspar 250mg tablets are indicated for breast cancer treatment. Their mechanism involves inhibiting or retarding cancerous cell proliferation. This medication may be administered alone or alongside other therapies to manage advanced breast cancer. Oncaspar 250mg tablets should be ingested on an empty stomach, or one hour prior to, or two hours after, a meal. Dosage and treatment length are tailored to disease severity and patient response. Adhere strictly to the prescribed regimen to minimize adverse reactions. Therapeutic benefits may not be evident for several weeks or months; discontinue use only upon your physician's instruction. Frequent adverse effects include nausea, headache, back pain, and dyspnea. Severe diarrhea may occur; ensure adequate hydration or seek medical advice if problematic. Regular blood pressure monitoring is often necessary during treatment. Report severe headache, confusion, visual disturbances, nausea, or vomiting to your doctor immediately. Liver function assessments are typically conducted before, during, and after treatment. Inform your physician of any pre-existing liver or kidney conditions before commencing treatment. Potential drug interactions exist; inform your healthcare provider of all concurrent medications. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners throughout the treatment period to prevent conception.

Uses of Abnib 250mg Tablet

Malignant mammary tumor

Major Benefits of Abnib 250mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Abnib 250mg Tablet should be administered on an empty stomach.

Common Side effects of Abnib 250mg Tablet:

  • Abdominal pain
  • Back pain
  • Breathing problems
  • Constipation
  • Cough
  • Diarrhea
  • Fatigue
  • Headache
  • Hot flashes
  • Increased bilirubin in the blood
  • Insomnia (difficulty in sleeping)
  • Joint pain
  • Liver damage
  • Loss of appetite
  • Mucosal inflammation
  • Nausea
  • Pain in extremities
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight gain

How to use Abnib 250mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 250mg Abnib tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication on an empty stomach.

How Abnib 250mg Tablet works:

Oncaspar 250mg tablets are a cancer treatment that targets HER2 and EGFR receptors, proteins that trigger excessive cell growth. By blocking these receptors, the drug prevents the signaling cascades responsible for cancer cell proliferation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Abnib 250mg Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Abnib 250mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the risks. Always seek medical counsel.

Breast feedingBreast feedingUNSAFE

Lactation and Abnib 250mg tablets are incompatible; the medication poses a potential risk of infant toxicity.

DrivingDrivingUNSAFE

Taking Abnib 250mg tablets might impair your driving ability due to potential adverse reactions.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Abnib 250mg tablets cautiously, potentially requiring dose modification. Medical advice is recommended. Data on Abnib 250mg tablet use in such patients is limited. Dosage alterations are not advised for individuals with mild or moderate kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Abnib 250mg Tablets cautiously, potentially requiring dose modification. Consult your physician. Data on Abnib 250mg Tablet use in patients with severe hepatic dysfunction is limited.

What if you forget to take Abnib 250mg Tablet :

Omit a scheduled Abnib 250mg Tablet? Seek medical advice.

Facts to Know About Abnib 250mg Tablet

LabelValue
Type of Compound Quinazoline-based amines
Addictive None.
Type of Medication Cancer therapeutics
Mechanism of Action Kinase inhibitors targeting tyrosine

FAQs on Abnib 250mg Tablet

This medication is a targeted anticancer agent, part of a class exhibiting more precise mechanisms than conventional chemotherapy. Abnib 250mg Tablet is a tyrosine kinase inhibitor, functioning by inhibiting the activity of a mutated protein responsible for signaling cancerous cell proliferation. This action contributes to the halting or retardation of cancer cell growth.
Abnib 250mg tablets are suitable for use alongside other anticancer medications. Commonly, they're administered concurrently with capecitabine for advanced breast cancer in patients who have received prior chemotherapy. Additionally, Abnib 250mg tablets are employed with letrozole in the treatment of breast cancer among postmenopausal women.
Follow your physician's instructions precisely when administering Abnib 250mg tablets. Ingest each tablet whole with water, maintaining consistent daily timing. Administer Abnib 250mg tablets one hour before or after meals, ensuring consistent timing relative to food intake (for example, consistently one hour prior to breakfast).
Abnib 250mg tablets pose a risk of liver injury, potentially severe or fatal. This liver damage may manifest within days or months of commencing treatment. Patients with a history of liver disease should disclose this to their physician. Seek immediate medical attention if you develop symptoms including jaundice (yellowing of skin or eyes), altered urine color, right upper abdominal pain, unusual bleeding or bruising, or abnormally pale or dark feces.
Should diarrhea develop while using Abnib 250mg tablets, increased fluid intake (8-10 glasses daily) is recommended. Suitable fluids include water, electrolyte beverages, and other clear liquids. A diet emphasizing lean protein and low-fat foods is advisable; avoid rich or spicy meals. Opt for cooked over raw vegetables, and peel fruits before consumption. Dairy products (including ice cream) and herbal remedies (some can exacerbate diarrhea) should be avoided. Persistent diarrhea warrants immediate medical attention; your doctor may adjust treatment based on its severity.
Your physician will assess your skin's condition prior to and throughout your treatment. Individuals with sensitive skin should utilize fragrance-free, hypoallergenic cleansers and cosmetics that are free of soap. Daily application of sunscreen with an SPF of 30 or greater is recommended. Report any skin rash to your doctor without delay.
Supplementary examinations may be necessary to assess cardiac and hepatic function. Abnib 250mg Tablet can alter cardiovascular performance, impacting both heart rhythm and blood flow. Your physician will closely observe you for any cardiological effects of Abnib 250mg Tablet and will also evaluate your liver health. Treatment modifications, including dose adjustments or cessation, will depend on the outcomes of these assessments.
Prevent pregnancy by employing reliable contraception during and for at least one week following your final dose of Abnib 250mg Tablet. Notify your physician immediately should pregnancy occur; they will determine the appropriate course of action regarding treatment continuation.
Abnib 250mg Tablet
6,898
MRP 8,404
17% off